Norway
At GSK, we unite science, technology and talent to get ahead of disease together.
We prevent and treat disease with specialty medicines, vaccines and general medicines investing in four core therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; infectious diseases.
Our Ahead Together strategy means intervening early to prevent and change the course of disease, helping to protect people and support healthcare systems.
GSK Norway employs approximately 70 people from different backgrounds, and our office is at Lysaker. We work with everything from medical projects to market access, marketing, sales and various support functions - all to provide Norwegian patients and society with needed new medicines and vaccines.
Research and innovation
Innovation is fundamental to us. It helps improve people's health and creates true value. We reinvest a significant proportion of our profits in new research.
We are convinced that collaborations lead to great innovations. We collaborate with healthcare, academia, patient organisations, governments, NGOs and other stakeholders through joint projects, training and by sharing our knowledge. GSK Norway is a part of Oslo Cancer Cluster (OCC), an oncology research and industry cluster dedicated to improving the lives of cancer patients by accelerating the development of new cancer diagnostics and treatment. Under the OCC umbrella, we are a part of CONNECT - a public-private partnership driving the implementation of precision cancer medicine.
Sustainability and global health
We use our scientific expertise, our partnerships and our global reach to improve health globally. We contribute to the UN Sustainable Development Goals and Agenda 2030 with various concrete actions. Through our global partnership with Save the Children, we have helped more than three million children.
We have set ambitious, industry leading environmental targets and created solutions that contribute to reducing carbon emissions, plastic consumption and water impact. GSK Norway has been in the forefront of educating stakeholders about the differences in carbon footprint between inhalers with or without greenhouse gases, used in the treatment of asthma and COPD. Also, GSK globally is a part of a coalition – together with among others the Norwegian government – to support high-quality emissions reductions from tropical and subtropical forest countries, enabling efforts to reduce and end deforestation (the LEAF cooperation).
Careers
Satisfied and motivated employees are the key to success. We do everything we can to make working at GSK a rewarding experience. We offer an equal and flexible workplace with a culture of care and integrity, where everyone can develop, feel good and thrive regardless of background.
In addition to a wide range of benefits, all employees have an extra day off, a so-called “Be You Day”, which each employee can spend as they wish, to bring joy and energy. Our Partnership for Prevention programme gives employees' families or near ones access to free preventive health care.
To find out how you can become part of GSK, search for jobs in Norway.
Contact details
Healthcare professionals and patient groups
Norway Transparency Act 2022
The Transparency Act was passed by Parliament and took effect on July 1st, 2022. The purpose of the law is to promote decent working conditions and basic human rights in addition to ensuring society's access to documents and matters dealt with by the general public.